198 related articles for article (PubMed ID: 25815673)
1. Inhibition of Myogenic Tone in Rat Cremaster and Cerebral Arteries by SKA-31, an Activator of Endothelial KCa2.3 and KCa3.1 Channels.
Mishra RC; Wulff H; Hill MA; Braun AP
J Cardiovasc Pharmacol; 2015 Jul; 66(1):118-27. PubMed ID: 25815673
[TBL] [Abstract][Full Text] [Related]
2. SKA-31, an activator of endothelial Ca
Khaddaj-Mallat R; Mathew John C; Braun AP
Eur J Pharmacol; 2018 Jul; 831():60-67. PubMed ID: 29753043
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Cardiovascular Function in Primary Hypertension in Rat by SKA-31, an Activator of
Kloza M; Baranowska-Kuczko M; Toczek M; Kusaczuk M; Sadowska O; Kasacka I; Kozłowska H
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450834
[TBL] [Abstract][Full Text] [Related]
4. KCa channel activation normalizes endothelial function in Type 2 Diabetic resistance arteries by improving intracellular Ca
Mishra RC; Kyle BD; Kendrick DJ; Svystonyuk D; Kieser TM; Fedak PWM; Wulff H; Braun AP
Metabolism; 2021 Jan; 114():154390. PubMed ID: 33039407
[TBL] [Abstract][Full Text] [Related]
5. Alpha
Mishra RC; Rahman MM; Davis MJ; Wulff H; Hill MA; Braun AP
Physiol Rep; 2018 May; 6(9):e13703. PubMed ID: 29756401
[TBL] [Abstract][Full Text] [Related]
6. Improvement of endothelium-dependent vasodilations by SKA-31 and SKA-20, activators of small- and intermediate-conductance Ca2+ -activated K+ -channels.
Hasenau AL; Nielsen G; Morisseau C; Hammock BD; Wulff H; Köhler R
Acta Physiol (Oxf); 2011 Sep; 203(1):117-26. PubMed ID: 21362152
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs.
Damkjaer M; Nielsen G; Bodendiek S; Staehr M; Gramsbergen JB; de Wit C; Jensen BL; Simonsen U; Bie P; Wulff H; Köhler R
Br J Pharmacol; 2012 Jan; 165(1):223-34. PubMed ID: 21699504
[TBL] [Abstract][Full Text] [Related]
8. A pharmacologic activator of endothelial KCa channels increases systemic conductance and reduces arterial pressure in an anesthetized pig model.
Mishra RC; Mitchell JR; Gibbons-Kroeker C; Wulff H; Belenkie I; Tyberg JV; Braun AP
Vascul Pharmacol; 2016 Apr; 79():24-31. PubMed ID: 26239885
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of endothelium-dependent vasodilation in pressurized cerebral and small mesenteric resistance arteries of the rat.
Lagaud GJ; Skarsgard PL; Laher I; van Breemen C
J Pharmacol Exp Ther; 1999 Aug; 290(2):832-9. PubMed ID: 10411599
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological Targeting of KCa Channels to Improve Endothelial Function in the Spontaneously Hypertensive Rat.
Khaddaj Mallat R; Mathew John C; Mishra RC; Kendrick DJ; Braun AP
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31315169
[TBL] [Abstract][Full Text] [Related]
11. Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure.
Sankaranarayanan A; Raman G; Busch C; Schultz T; Zimin PI; Hoyer J; Köhler R; Wulff H
Mol Pharmacol; 2009 Feb; 75(2):281-95. PubMed ID: 18955585
[TBL] [Abstract][Full Text] [Related]
12. Activation of KCa3.1 by SKA-31 induces arteriolar dilatation and lowers blood pressure in normo- and hypertensive connexin40-deficient mice.
Radtke J; Schmidt K; Wulff H; Köhler R; de Wit C
Br J Pharmacol; 2013 Sep; 170(2):293-303. PubMed ID: 23734697
[TBL] [Abstract][Full Text] [Related]
13. The influence of DOCA-salt hypertension and chronic administration of the FAAH inhibitor URB597 on K
Kloza M; Baranowska-Kuczko M; Malinowska B; Karpińska O; Harasim-Symbor E; Kasacka I; Kozłowska H
Vascul Pharmacol; 2017 Dec; 99():65-73. PubMed ID: 29038048
[TBL] [Abstract][Full Text] [Related]
14. Vascular Reactivity Profile of Novel KCa 3.1-Selective Positive-Gating Modulators in the Coronary Vascular Bed.
Oliván-Viguera A; Valero MS; Pinilla E; Amor S; García-Villalón ÁL; Coleman N; Laría C; Calvín-Tienza V; García-Otín ÁL; Fernández-Fernández JM; Murillo MD; Gálvez JA; Díaz-de-Villegas MD; Badorrey R; Simonsen U; Rivera L; Wulff H; Köhler R
Basic Clin Pharmacol Toxicol; 2016 Aug; 119(2):184-92. PubMed ID: 26821335
[TBL] [Abstract][Full Text] [Related]
15. SKA-31, an activator of Ca
John CM; Khaddaj Mallat R; Mishra RC; George G; Singh V; Turnbull JD; Umeshappa CS; Kendrick DJ; Kim T; Fauzi FM; Visser F; Fedak PWM; Wulff H; Braun AP
Pharmacol Res; 2020 Jan; 151():104539. PubMed ID: 31707036
[TBL] [Abstract][Full Text] [Related]
16. A novel pan-negative-gating modulator of KCa2/3 channels, fluoro-di-benzoate, RA-2, inhibits endothelium-derived hyperpolarization-type relaxation in coronary artery and produces bradycardia in vivo.
Oliván-Viguera A; Valero MS; Coleman N; Brown BM; Laría C; Murillo MD; Gálvez JA; Díaz-de-Villegas MD; Wulff H; Badorrey R; Köhler R
Mol Pharmacol; 2015 Feb; 87(2):338-48. PubMed ID: 25468883
[TBL] [Abstract][Full Text] [Related]
17. Ca2+-activated K+ channels of small and intermediate conductance control eNOS activation through NAD(P)H oxidase.
Gaete PS; Lillo MA; Ardiles NM; Pérez FR; Figueroa XF
Free Radic Biol Med; 2012 Mar; 52(5):860-70. PubMed ID: 22210378
[TBL] [Abstract][Full Text] [Related]
18. Prominent role of KCa3.1 in endothelium-derived hyperpolarizing factor-type dilations and conducted responses in the microcirculation in vivo.
Wölfle SE; Schmidt VJ; Hoyer J; Köhler R; de Wit C
Cardiovasc Res; 2009 Jun; 82(3):476-83. PubMed ID: 19218287
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic targeting of endothelial Ca
Mathew John C; Khaddaj Mallat R; George G; Kim T; Mishra RC; Braun AP
Channels (Austin); 2018 Jan; 12(1):126-136. PubMed ID: 29577810
[TBL] [Abstract][Full Text] [Related]
20. SKA-31, a novel activator of SK(Ca) and IK(Ca) channels, increases coronary flow in male and female rat hearts.
Mishra RC; Belke D; Wulff H; Braun AP
Cardiovasc Res; 2013 Feb; 97(2):339-48. PubMed ID: 23118129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
